Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico, Notification of Proposed Production Activity, Bristol-Myers Squibb Holdings Pharma, Ltd. (Pharmaceuticals), Manati, Puerto Rico, 23759-23760 [2019-10805]
Download as PDF
khammond on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 84, No. 100 / Thursday, May 23, 2019 / Notices
Reduction Act of 1995 (Pub. L. 104–113)
and Office of Management and Budget
regulations at 5 CFR part 1320.
NASS also complies with OMB
Implementation Guidance,
‘‘Implementation Guidance for Title V
of the E-Government Act, Confidential
Information Protection and Statistical
Efficiency Act of 2002 (CIPSEA),’’
Federal Register, Vol. 72, No. 115, June
15, 2007, p. 33362.
Estimate of Burden: Public reporting
burden for this information collection is
based on approximately 55 individual
surveys with expected response times of
5–60 minutes. The frequency of data
collection for the different surveys will
include annual, seasonal, quarterly,
monthly, and one weekly survey.
Estimated number of responses per
respondent is 1.1. Publicity materials
and instruction sheets will account for
approximately 5 minutes of additional
burden per respondent. Respondents
who refuse to complete a survey will be
allotted 2 minutes of burden per attempt
to collect the data. Several new surveys
have been added to this information
collection to account for some specialty
commodities conducted under
cooperative agreements with several
States.
Respondents: Producers, processors,
and handlers.
Estimated Number of Respondents:
75,000.
Estimated Total Annual Burden on
Respondents: 26,000 hours.
Comments: Comments are invited on:
(a) Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information including the validity of
the methodology and assumptions used;
(c) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on those who are to respond, through
the use of appropriate automated,
electronic, mechanical, technological or
other forms of information technology
collection methods.
All responses to this notice will
become a matter of public record and be
summarized in the request for OMB
approval.
Signed at Washington, DC, May 2, 2019.
Kevin L. Barnes,
Associate Administrator.
[FR Doc. 2019–10782 Filed 5–22–19; 8:45 am]
BILLING CODE 3410–20–P
VerDate Sep<11>2014
16:40 May 22, 2019
Jkt 247001
COMMISSION ON CIVIL RIGHTS
Notice of Public Meeting of the Nevada
Advisory Committee
U.S. Commission on Civil
Rights.
ACTION: Announcement of meeting.
AGENCY:
Notice is hereby given,
pursuant to the provisions of the rules
and regulations of the U.S. Commission
on Civil Rights (Commission) and the
Federal Advisory Committee Act
(FACA) that a meeting of the Nevada
Advisory Committee (Committee) to the
Commission will be held at 2:00 p.m.
(Pacific Time) Thursday, May 30, 2019,
the purpose of meeting is for the
Committee to debrief the May 3, 2019
Community Forum.
DATES: The meeting will be held on
Thursday, May 30, 2019 at 2:00 p.m. PT.
Public Call Information: Dial: 877–
260–1479, Conference ID: 6760059.
FOR FURTHER INFORMATION CONTACT: Ana
Victoria Fortes (DFO) at afortes@
usccr.gov or (213) 894–3437.
SUPPLEMENTARY INFORMATION: This
meeting is available to the public
through the following toll-free call-in
number: 877–260–1479, conference ID
number: 6760059. Any interested
member of the public may call this
number and listen to the meeting.
Callers can expect to incur charges for
calls they initiate over wireless lines,
and the Commission will not refund any
incurred charges. Callers will incur no
charge for calls they initiate over landline connections to the toll-free
telephone number. Persons with hearing
impairments may also follow the
proceedings by first calling the Federal
Relay Service at 1–800–877–8339 and
providing the Service with the
conference call number and conference
ID number.
Members of the public are entitled to
make comments during the open period
at the end of the meeting. Members of
the public may also submit written
comments; the comments must be
received in the Regional Programs Unit
within 30 days following the meeting.
Written comments may be mailed to the
Western Regional Office, U.S.
Commission on Civil Rights, 300 North
Los Angeles Street, Suite 2010, Los
Angeles, CA 90012. They may be faxed
to the Commission at (213) 894–0508, or
emailed Ana Victoria Fortes at afortes@
usccr.gov. Persons who desire
additional information may contact the
Regional Programs Unit at (213) 894–
3437.
Records and documents discussed
during the meeting will be available for
public viewing prior to and after the
SUMMARY:
PO 00000
Frm 00006
Fmt 4703
Sfmt 4703
23759
meeting at https://
www.facadatabase.gov/FACA/FACA
PublicViewCommitteeDetails?id=
a10t0000001gzlJAAQ.
Records generated from this meeting
may also be inspected and reproduced
at the Regional Programs Unit, as they
become available, both before and after
the meeting. Persons interested in the
work of this Committee are directed to
the Commission’s website, https://
www.usccr.gov, or may contact the
Regional Programs Unit at the above
email or street address.
Agenda
I. Welcome
II. Approval of Minutes for May 3, 2019
Community Forum
III. Debrief May 3 Community Forum
IV. Discuss Report Writing Schedule
V. Public Comment
VI. Next Steps
VII. Adjournment
Exceptional Circumstance: Pursuant
to 41 CFR 102–3.150, the notice for this
meeting is given less than 15 calendar
days prior to the meeting because of the
exceptional circumstances of the federal
government shutdown.
Dated: May 18, 2019.
David Mussatt,
Supervisory Chief, Regional Programs Unit.
[FR Doc. 2019–10758 Filed 5–22–19; 8:45 am]
BILLING CODE P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–36–2019]
Foreign-Trade Zone (FTZ) 7—
Mayaguez, Puerto Rico, Notification of
Proposed Production Activity, BristolMyers Squibb Holdings Pharma, Ltd.
(Pharmaceuticals), Manati, Puerto Rico
Bristol-Myers Squibb Holdings
Pharma, Ltd. (BMS) submitted a
notification of proposed production
activity to the FTZ Board for its facility
in Manati, Puerto Rico. The notification
conforming to the requirements of the
regulations of the FTZ Board (15 CFR
400.22) was received on May 13, 2019.
BMS already has authority to produce
certain pharmaceutical products within
Subzone 7J. The current request would
add finished products and a foreign
status material/component to the scope
of authority. Pursuant to 15 CFR
400.14(b), additional FTZ authority
would be limited to the specific foreignstatus material/component and specific
finished products described in the
submitted notification (as described
below) and subsequently authorized by
the FTZ Board.
E:\FR\FM\23MYN1.SGM
23MYN1
23760
Federal Register / Vol. 84, No. 100 / Thursday, May 23, 2019 / Notices
Production under FTZ procedures
could exempt BMS from customs duty
payments on the foreign-status
materials/components used in export
production. On its domestic sales, for
the foreign-status material/component
noted below and in the existing scope
of authority, BMS would be able to
choose the duty rates during customs
entry procedures that apply to
pegbelfermin in measured and finished
dosages (duty-free). BMS would be able
to avoid duty on foreign-status
components which become scrap/waste.
Customs duties also could possibly be
deferred or reduced on foreign-status
production equipment.
The material/component sourced
from abroad is pegbelfermin—active
pharmaceutical ingredient (duty-free).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is July 2,
2019.
A copy of the notification will be
available for public inspection in the
‘‘Reading Room’’ section of the Board’s
website, which is accessible via
www.trade.gov/ftz.
For further information, contact
Christopher Wedderburn at
Chris.Wedderburn@trade.gov or (202)
482–1963.
Dated: May 17, 2019.
Andrew McGilvray,
Executive Secretary.
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–77–2018]
Foreign-Trade Zone (FTZ) 168—Dallas/
Fort Worth, Texas, Authorization of
Production Activity, Gulfstream
Aerospace Corporation (Disassembly
of Aircraft), Dallas, Texas
khammond on DSKBBV9HB2PROD with NOTICES
[FR Doc. 2019–10806 Filed 5–22–19; 8:45 am]
On December 7, 2018, the Metroplex
International Trade Development
Corporation, grantee of FTZ 168,
submitted a notification of proposed
production activity to the FTZ Board on
behalf of Gulfstream Aerospace
Corporation, within Subzone168E, in
Dallas, Texas.
The notification was processed in
accordance with the regulations of the
FTZ Board (15 CFR part 400), including
notice in the Federal Register inviting
public comment (83 FR 64517–64518,
December 17, 2018). On May 16, 2019,
the applicant was notified of the FTZ
Jkt 247001
DEPARTMENT OF COMMERCE
International Trade Administration
[C–570–085]
Certain Quartz Surface Products From
the People’s Republic of China: Final
Affirmative Countervailing Duty
Determination, and Final Affirmative
Determination of Critical
Circumstances
BILLING CODE 3510–DS–P
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department of Commerce
(Commerce) determines that
countervailable subsidies are being
provided to producers and exporters of
certain quartz surface products (quartz
surface products) from the People’s
Republic of China (China).
DATES: Applicable May 23, 2019.
FOR FURTHER INFORMATION CONTACT:
Darla Brown or Joshua Tucker, AD/CVD
Operations, Office II, Enforcement and
Compliance, International Trade
Administration, U.S. Department of
Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone:
(202) 482–1791 or (202) 482–2044,
respectively.
AGENCY:
DEPARTMENT OF COMMERCE
International Trade Administration
[C–489–832]
Carbon and Alloy Steel Wire Rod From
Turkey: Correction to Notice of
Opportunity To Request Administrative
Review
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
AGENCY:
FOR FURTHER INFORMATION CONTACT:
Brenda E. Waters, AD/CVD Operations,
Customs Liaison Unit, Enforcement and
Compliance, International Trade
Administration, U.S. Department of
Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone:
(202) 482–4735.
Background
BILLING CODE 3510–DS–P
16:40 May 22, 2019
Dated: May 16, 2019.
Andrew McGilvray,
Executive Secretary.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–10805 Filed 5–22–19; 8:45 am]
VerDate Sep<11>2014
Board’s decision that no further review
of the activity is warranted at this time.
The production activity described in the
notification was authorized, subject to
the FTZ Act and the FTZ Board’s
regulations, including Section 400.14.
On May 1, 2019, Commerce published
its notification to parties of the
opportunity to request an administrative
review of countervailing duty orders
and inadvertently omitted Carbon and
Alloy Steel Wire Rod from Turkey (C–
489–832), POR 9/5/2017–12/31/2018.
See Antidumping or Countervailing
Duty Order, Finding, or Suspended
Investigation; Opportunity To Request
Administrative Review, 84 FR 18479
(May 1, 2019).
This notice serves as a correction to
include the countervailing duty order
Carbon and Alloy Steel Wire Rod from
Turkey (C–489–832) administrative
review in the referenced notice.
Dated: May 16, 2019.
Gary Taverman,
Deputy Assistant Secretary for Antidumping
and Countervailing Duty Operations.
[FR Doc. 2019–10804 Filed 5–22–19; 8:45 am]
BILLING CODE 3510–DS–P
PO 00000
Frm 00007
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
Background
The petitioner in this investigation is
Cambria Company, LLC. In addition to
the Government of China (GOC), the
mandatory respondents in this
investigation are Fasa Industrial
Corporation Limited (Fasa Industrial),
Foshan Hero Stone Co., Ltd. (Hero
Stone), and Foshan Yixin Stone Co.,
Ltd. (Foshan Yixin).
The events that occurred since
Commerce published the Preliminary
Determination 1 on September 21, 2018;
the post-preliminary analysis 2 on
November 6, 2018; and the Preliminary
Critical Circumstances Determination 3
on November 15, 2018, are discussed in
the Issues and Decision Memorandum,
1 See Certain Quartz Surface Products from the
People’s Republic of China: Preliminary Affirmative
Countervailing Duty Determination, and Alignment
of Final Determination with Final Antidumping
Duty Determination, 83 FR 47881 (September 21,
2018) (Preliminary Determination), and
accompanying Preliminary Decision Memorandum.
2 See Memorandum, ‘‘Post-Preliminary Analysis
of Countervailing Duty Investigation: Certain Quartz
Surface Products from the People’s Republic of
China,’’ dated November 6, 2018.
3 See Certain Quartz Surface Products from the
People’s Republic of China: Preliminary Affirmative
Determination of Critical Circumstances, in Part, in
the Countervailing Duty Investigation, 83 FR 57419
(November 15, 2018) (Preliminary Critical
Circumstances Determination).
E:\FR\FM\23MYN1.SGM
23MYN1
Agencies
[Federal Register Volume 84, Number 100 (Thursday, May 23, 2019)]
[Notices]
[Pages 23759-23760]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10805]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-36-2019]
Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico, Notification
of Proposed Production Activity, Bristol-Myers Squibb Holdings Pharma,
Ltd. (Pharmaceuticals), Manati, Puerto Rico
Bristol-Myers Squibb Holdings Pharma, Ltd. (BMS) submitted a
notification of proposed production activity to the FTZ Board for its
facility in Manati, Puerto Rico. The notification conforming to the
requirements of the regulations of the FTZ Board (15 CFR 400.22) was
received on May 13, 2019.
BMS already has authority to produce certain pharmaceutical
products within Subzone 7J. The current request would add finished
products and a foreign status material/component to the scope of
authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would
be limited to the specific foreign-status material/component and
specific finished products described in the submitted notification (as
described below) and subsequently authorized by the FTZ Board.
[[Page 23760]]
Production under FTZ procedures could exempt BMS from customs duty
payments on the foreign-status materials/components used in export
production. On its domestic sales, for the foreign-status material/
component noted below and in the existing scope of authority, BMS would
be able to choose the duty rates during customs entry procedures that
apply to pegbelfermin in measured and finished dosages (duty-free). BMS
would be able to avoid duty on foreign-status components which become
scrap/waste. Customs duties also could possibly be deferred or reduced
on foreign-status production equipment.
The material/component sourced from abroad is pegbelfermin--active
pharmaceutical ingredient (duty-free).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is July 2, 2019.
A copy of the notification will be available for public inspection
in the ``Reading Room'' section of the Board's website, which is
accessible via www.trade.gov/ftz.
For further information, contact Christopher Wedderburn at
[email protected] or (202) 482-1963.
Dated: May 17, 2019.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2019-10805 Filed 5-22-19; 8:45 am]
BILLING CODE 3510-DS-P